Publicado en

Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).

ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease

en

Keith C Norris, Karen E Smoyer, Catherine Rolland, Jan Van der Vaart, Elizabeth Grubb  

 

 BMC Nephrol. 2018;19(1):36. 

 

Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM). In this systematic literature review, the authors examined the literature documenting the role of albuminuria, serum creatinine, eGFR and uric acid in predicting kidney disease progression and cardio-renal outcomes in people with T2DM. 

 

The authors found that kidney disease progression differed substantially across publications and that the biomarker measurements were diverse. They also noted that GFR loss and the doubling of serum creatinine were the most frequently reported outcome measures. Numerous publications also presented risk estimates for albuminuria and serum creatinine, or both.  

 

The authors concluded that, despite the utility of albuminuria, serum creatinine and eGFR as predictors of kidney disease progression, effort is required to harmonize biomarker measurements. This would help better establish the clinical significance of these biomarkers in people with T2DM. 

 

The full publication can be accessed here. 

 

 

COL-12527 03/2022 

 

Noticias relacionadas

Cards

  • Publicado en

    Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Eliseo Guallar, Tazeen Jafar, Simerjot K Jassal, Gijs W D Landman, Paul Muntner, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael Shlipak, Marcello Tonelli, Jonathan Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron Gansevoort, Mark Sarnak, David G Warnock, Mark Woodward, Johan Ärnlöv, CKD Prognosis Consortium

    Estimated glomerular filtration rate and albumin-to-creatinine ratio testing for cardiovascular risk assessment

    en
    Acceder ya
    Restricted
  • Publicado en

    Johan Sundström, Johan Bodegard, Andreas Bollmann, Marc G Vervloet, Patrick B Mark, Avraham Karasik, Tiago Taveira-Gomes, Manuel Botana, Kåre I Birkeland, Marcus Thuresson, Levy Jäger, Manish M Sood, Gijs VanPottelbergh, Navdeep Tangri; on behalf of the CaReMe CKD Investigators

    Prevalence, outcomes and cost of chronic kidney disease

    en
    Acceder ya
    Restricted
  • Publicado en

    Marleen Smits, Rogier Hopstaken, Lusan Terhaag, Gijs de Kort, Paul Giesen

    HbA1c and glucose point‑of‑care testing in general practice

    en
    Acceder ya
    Restricted